[Intervention therapy for secondary hyperparathyroidism]

Area of Science:

• Nephrology
• Endocrinology
• Interventional Radiology

Context:

• Severe secondary hyperparathyroidism (2HPT) is a common complication in patients with chronic kidney disease undergoing dialysis.
• Traditional medical management of 2HPT can be challenging, necessitating alternative therapeutic approaches.
• Percutaneous interventions have emerged as viable options for managing hyperparathyroidism in uremia.

Purpose:

• To evaluate the efficacy of selective percutaneous ethanol injection therapy (PEIT) for secondary hyperparathyroidism in chronic dialysis patients.
• To summarize guidelines for PEIT based on a Japanese Working Group survey and pathophysiological considerations.
• To introduce alternative percutaneous injection therapies (PIT) and highlight the role of interventional radiology (IVR) in hyperparathyroidism management.

Summary:

• Selective PEIT guided by color Doppler flow mapping demonstrates effectiveness in treating severe secondary hyperparathyroidism in chronic dialysis patients.
• A Japanese survey indicated over 600 PEIT treatments by September 1998, leading to proposed treatment guidelines.
• Alternative PIT methods using calcitriol, maxacalcitol, and acetic acid are also discussed, alongside the broader utility of IVR.

Impact:

• PEIT provides an effective, minimally invasive adjunct to medical therapy for hyperparathyroidism in uremia.
• The development of guidelines for PEIT supports its standardized and safer application.
• Emerging PIT techniques and IVR expand therapeutic options for managing complex hyperparathyroidism in renal disease.